- Previous Close
34.80 - Open
34.75 - Bid 34.25 x --
- Ask 34.55 x --
- Day's Range
34.05 - 34.80 - 52 Week Range
27.50 - 38.50 - Volume
49,451 - Avg. Volume
85,761 - Market Cap (intraday)
1.826B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
19.17 - EPS (TTM)
1.80 - Earnings Date --
- Forward Dividend & Yield 0.70 (2.03%)
- Ex-Dividend Date Jul 16, 2024
- 1y Target Est
--
Bioptik Technology Incorporation engages in the production and sale of medical devices and reagents worldwide. It offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. The company also provides skin care products and dietary supplements, as well as biodiesel products. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.
www.bioptik.com.twRecent News: 4161.TWO
View MorePerformance Overview: 4161.TWO
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4161.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4161.TWO
View MoreValuation Measures
Market Cap
1.83B
Enterprise Value
1.86B
Trailing P/E
19.17
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.07
Price/Book (mrq)
2.03
Enterprise Value/Revenue
2.14
Enterprise Value/EBITDA
11.96
Financial Highlights
Profitability and Income Statement
Profit Margin
10.81%
Return on Assets (ttm)
3.76%
Return on Equity (ttm)
10.68%
Revenue (ttm)
865.33M
Net Income Avi to Common (ttm)
93.57M
Diluted EPS (ttm)
1.80
Balance Sheet and Cash Flow
Total Cash (mrq)
422.29M
Total Debt/Equity (mrq)
41.59%
Levered Free Cash Flow (ttm)
115.68M